1. Home
  2. CAC vs QSI Comparison

CAC vs QSI Comparison

Compare CAC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$49.00

Market Cap

781.2M

Sector

Finance

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.73

Market Cap

161.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
QSI
Founded
1875
2013
Country
United States
United States
Employees
N/A
145
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
781.2M
161.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CAC
QSI
Price
$49.00
$0.73
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$45.50
$1.00
AVG Volume (30 Days)
76.2K
2.9M
Earning Date
04-28-2026
05-14-2026
Dividend Yield
3.48%
N/A
EPS Growth
6.08
N/A
EPS
3.84
N/A
Revenue
$41,739,000.00
N/A
Revenue This Year
$19.15
N/A
Revenue Next Year
$6.05
$618.07
P/E Ratio
$12.56
N/A
Revenue Growth
16.96
N/A
52 Week Low
$34.53
$0.72
52 Week High
$51.57
$3.10

Technical Indicators

Market Signals
Indicator
CAC
QSI
Relative Strength Index (RSI) 64.93 33.24
Support Level $41.94 N/A
Resistance Level $51.36 $1.11
Average True Range (ATR) 1.08 0.05
MACD 0.37 -0.01
Stochastic Oscillator 100.00 8.34

Price Performance

Historical Comparison
CAC
QSI

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: